CPT Revenue Growth (YoY) Analysis
Updated 273h ago·SEC filings & market data
Key Takeaway
Revenue growth YoY of -0.5% means revenue shrank 0.5% versus the same period last year, a basic sign of contracting sales.
Sector Performance
13th percentileCPT
-0.5%
Sector Median
9.0%
Sector Avg
14.8%
Prior Period
0.1%(May 2026)
Deep Analysis
Revenue growth YoY of -0.5% means revenue shrank 0.5% versus the same period last year, a basic sign of contracting sales.
Compared to sector peers, this trails the 8.9% sector median and sits at the 13th percentile, meaning 87% of peers grew faster. The trend direction is N/A, with no year-over-year change or quarter-over-quarter change reported, and no eight-quarter history available to assess momentum. The negative growth level, paired with absent trend data, leaves no evidence of recovery, pointing to elevated investment risk. This metric supports the overall CAUTIOUS verdict directly, as negative revenue growth far below the sector norm justifies caution.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about CPT?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Who are CPT's closest peers by Revenue Growth (YoY)?
The closest peers by Revenue Growth (YoY) include: TMUS (7.9%), MCK (7.7%), SIEGY (7.3%), CB (7.2%), MHK (6.8%).
Learn More About Revenue Growth (YoY)
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master CPT's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CPT research report →CPT
-0.5%
Sector Median
9.0%
Sector Avg
14.8%
How CPT's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.